Decreased high-density lipoprotein cholesterol level is an independent correlate of circulating tumor necrosis factor-α in a general population

Clinical Cardiology

Volumn 32, Issue 9, 2009, Pages

  Yamagishi, Sho Ichi ^a   Adachi, Hisashi ^a   Matsui, Takanori ^a   Nakamura, Kazuo ^a   Enomoto, Mika ^a   Fukami, Ako ^a   Otsuka, Maki ^a   Kumagae, Shun Ichi ^a   Nanjo, Yasuki ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

ADULT; AGED; ANAMNESIS; ARTICLE; BLOOD CHEMISTRY; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; JAPAN; LINEAR MODELS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RISK ASSESSMENT; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 70249085900     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20517     Document Type: Article

References (21)

1. Manitovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB J. 1992;6:2591-2599.
2. Bruunsgaard H, Skinhoj P, Pedersen AN, Schroll M, Pedersen BK. Ageing, tumor necrosis factor-α (TNF-α) and atherosclerosis. Clin Exp Immunol. 2000;121:255-260. (Pubitemid 30659762)
3. Yamagishi S, Inagaki Y, Abe R, et al. Nifedipine inhibits apoptotic cell death of cultured endothelial cells induced by tumor necrosis factor-α. Drugs Exp Clin Res. 2003;29:141-145. (Pubitemid 38282341)
4. Yamagishi S, Inagaki Y, Kikuchi S. Nifedipine inhibits tumor necrosis factor-α -induced monocyte chemoattractant protein-1 overexpression by blocking NADPH oxidase-mediated reactive oxygen species generation. Drugs Exp Clin Res. 2003;29:147-152. (Pubitemid 38282342)
5. Yamagishi S, Nakamura K, Matsui T. Role of oxidative stress in the development of vascular injury and its therapeutic intervention by nifedipine. Curr Med Chem. 2008;15:172-177. (Pubitemid 351234620)
6. Skoog T, Dichtl W, Boquist S, et al. Plasma tumor necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J. 2002;23:376-383. (Pubitemid 35204198)
7. Ridker PM, Rifai N, Pfeffer M, et al. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000;101:2149-2153. (Pubitemid 30253042)
8. Enomoto M, Adachi H, Yamagishi S, et al. Positive association of serum levels of advanced glycation end products with thrombogenic markers in humans. Metabolism. 2006;55:912-917. (Pubitemid 43902894)
9. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor-α inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA. 1994;91:4854-4858. (Pubitemid 24177748)
10. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science. 1993;259:87-91. (Pubitemid 23036092)
11. Matsushita K, Yatsuya H, Tamakoshi K, et al. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol. 2006;26:871-876. (Pubitemid 43732165)
12. Moon YS, Kim DH, Song DK. Serum tumor necrosis factor-α levels and components of the metabolic syndrome in obese adolescents. Metabolism. 2004;53:863-867.
13. Nilsson J, Jovinge S, Niemann A, Reneland R, Lithell H. Relation between plasma tumor necrosis factor-α and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1998;18:11991-21201 (Pubitemid 28376175)
14. Borst SE. The role of TNF-α in insulin resistance. Endocrine. 2004;23:177-182.
15. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15:2792-2800.
16. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest. 1995;95:2409-2415.
17. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res. 2001;89:763-771. (Pubitemid 34633846)
18. Burger D, Dayer JM. High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation? Autoimmun Rev. 2002;1:111-117. (Pubitemid 38367434)
19. Calabresi L, Rossoni G, Gomaraschi M, et al. High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-α content and enhancing prostaglandin release. Circ Res. 2003;92:330-337. (Pubitemid 36258556)
20. Klimov AN, Gurevich VS, Nikiforova AA, et al. Antioxidative activity of high density lipoproteins in vivo. Atherosclerosis. 1993;100:13-18. (Pubitemid 23166004)
21. Kontush A, de Faria EC, Chantepie S, Chapman MJ. A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity. Atherosclerosis. 2005;182:277-285. (Pubitemid 41267195)